Citius Pharmaceuticals Statistics
NASDAQ: CTXRHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.5011+0.0204 (+4.24%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 0.5037 +0.52%
Citius Pharmaceuticals by the numbers
Citius Pharmaceuticals has a market capitalization of $13.8 million based on 27.45M shares outstanding. With trailing EPS of $-1.75, Citius Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.4% below its 50-day average and 27.8% below its 200-day average.
Average daily trading volume is 528.79K shares, or about $264,976 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CTXR valuation vs. peer median
| Metric | CTXR | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.76M | $14.08M | -2% |
| Avg. volume | 528.79K | 544.76K | -3% |
Peer median across 8 companies: BFRI, LTRN, TPST, CLRB, HIND, BFRG, KPTI, TVRD.
Valuation
- Market cap
- $13.76M
- EPS (TTM)
- $-1.75
- Shares outstanding
- 27.45M
Price and trading
- Previous close
- 0.4807
- Open
- 0.4889
- Day range
- 0.4879 – 0.51
- 52-week range
- 0.469 – 2.19
- 52-week change
- -64.21%
- 50-day moving average
- 0.5991
- 200-day moving average
- 0.6937
- Beta
- —
- Volume
- 156.68K
- Average volume
- 528.79K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2026
Additional statistics
- Market Cap
- 13.76M
- Forward Pe
- -0.35
- Eps
- -1.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.19
- Week52 Low
- 0.47
- Avg Volume
- 528.79K
- Shares Outstanding
- 27.45M
- Ma50
- 0.60
- Ma200
- 0.69
- Earnings Date
- Aug 14, 2026
- Pct From52w High
- -77.12%
- Pct From52w Low
- 6.84%